## **Core Concept**
The patient's presentation suggests lung cancer, likely small cell lung carcinoma (SCLC) given the central location of the mass, smoking history, and symptoms of shortness of breath and hemoptysis. Hypercalcemia in this context is often due to paraneoplastic syndromes.

## **Why the Correct Answer is Right**
The correct answer, **Parathyroid Hormone-related Protein (PTHrP)**, is a substance commonly associated with hypercalcemia of malignancy, particularly in squamous cell lung carcinoma but also in other types. PTHrP mimics the action of parathyroid hormone (PTH), leading to increased calcium levels in the blood by promoting bone resorption and renal calcium reabsorption.

## **Why Each Wrong Option is Incorrect**
- **Option A: Prostaglandins** - While prostaglandins can contribute to hypercalcemia by promoting bone resorption, they are not the primary substance associated with paraneoplastic hypercalcemia in lung cancer.
- **Option B: Calcitonin** - Calcitonin actually works to decrease serum calcium levels by inhibiting osteoclast activity and promoting calcium excretion by the kidneys. Its elevation is more commonly associated with medullary thyroid carcinoma.
- **Option C: Erythropoietin** - Erythropoietin is involved in the production of red blood cells and is not directly related to calcium metabolism.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **PTHrP-mediated hypercalcemia** is a common paraneoplastic syndrome in lung cancer, particularly in squamous cell carcinoma but also in small cell lung carcinoma. This condition requires prompt recognition and management as part of the patient's cancer treatment.

## **Correct Answer:** D. Parathyroid Hormone-related Protein (PTHrP).